Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention

Clinical Cardiology

Volumn 32, Issue 6, 2009, Pages 315-320

  Arora, Sandeep ^a   Alfayoumi, Fadi ^a   Khawaja, Azimuddin Tareq ^a   Dua, Aashish ^a   Srinivasan, Venkatraman ^a   Gradman, Alan H ^a  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICARDIPINE; NITRIC ACID DERIVATIVE; PACLITAXEL; PLACEBO; SODIUM CHLORIDE; TROPONIN I;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG ELUTING STENT; EXERCISE TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUSCLE NECROSIS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY DISEASE; CREATINE KINASE, MB FORM; DOUBLE-BLIND METHOD; HEART DISEASES; HUMANS; INJECTIONS, INTRA-ARTERIAL; LOGISTIC MODELS; MYOCARDIUM; NECROSIS; NICARDIPINE; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; STENTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I;

EID: 67650458571     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20580     Document Type: Article

References (26)

1. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase - myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol. 2000;35(5):1134-1141. (Pubitemid 30206886)
2. Okmen E, Kasikcioglu H, Sanli A, Uyarel H, Cam N. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. J Invasive Cardiol. 2005;17(2):63-67. (Pubitemid 41724720)
3. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Catheter Cardiovasc Interv. 2001;53(2):188-192. (Pubitemid 32532178)
4. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DRJr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006;48(9):1765-1770. (Pubitemid 44648624)
5. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol. 2003;92(2-3): 285-293. (Pubitemid 37509996)
6. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Sciascio GD. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation. 2004;110(6):674-678. (Pubitemid 39056265)
7. Bonz AW, Lengenfelder B, Strotmann J, et al. Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial). J Am Coll Cardiol. 2002;40(4):662-668. (Pubitemid 34925612)
8. Lee CH, Low A, Tai BC, et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study. Eur Heart J. 2007;28(1):19-25. (Pubitemid 46137813)
9. Kurz DJ, Naegeli B, Bertel O. A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting. Am Heart J. 2000;139(1 Pt 1): 35-43. (Pubitemid 30043622)
10. Murakami M, Iwasaki K, Kusachi S, et al. Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting. Int J Cardiol. 2006;107(1):48-53. (Pubitemid 41781743)
11. Jang YH, Kim JM. Nicardipine augments local myocardial perfusion after coronary artery reperfusion in dogs. J Korean Med Sci. 2003;18(1):23-26. (Pubitemid 38021787)
12. Fugit MD, Rubal BJ, Donovan DJ. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. J Invasive Cardiol. 2000;12(2):80-85.
13. Huang RI, Patel P, Walinsky P, et al. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;68(5):671-676. (Pubitemid 44721085)
14. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin-T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem. 2000;37:764-769. (Pubitemid 30835665)
15. Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Sciascio GD. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarctionin patients undergoing coronary intervention. Circulation. 2005;111:2099-2106.
16. Izgi A, Tanalp AC, Kirma C, et al. Predictors and prognostic significance of troponin I release following elective coronary angioplasty. J Int Med Res. 2006;34(6):612-623. (Pubitemid 46165385)
17. Ricciardi MJ, Davidson CJ, Gubernikoff G, et al. Troponin-I elevation and cardiac events after percutaneous coronary intervention. Am Heart J. 2003;145:522-528. (Pubitemid 36390500)
18. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111(8): 1027-1032. (Pubitemid 40354521)
19. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002; 105(5):554-556. (Pubitemid 34123427)
20. Steinhubl SR, Berger PB, Mann JT III, et al. Clopidogrel for the reduction of events during observation; early and sustained dual anti-platelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288: 2411-2420.
21. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans. J Am Coll Cardiol. 2007;49:1289-1295.
22. Hink U, Daiber A, Kayhan N, et al. Oxidative inhibition of the mitochondrial aldehyde dehydrogenase promotes nitroglycerin tolerance in human blood vessels. J Am Coll Cardiol. 2007;50: 2226-2232. (Pubitemid 350166814)
23. Fischell TA, Subraya RG, Ashraf K, Perry B, Haller S. "Pharmacological" distal protection using prophylactic intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention. J Invasive Cardiol. 2007;19(2):58-62.
24. Murakami M, Iwasaki K, Kusachi S, et al. Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting. Int J Cardiol. 2007;107:48-53.
25. Vijayalakshmi K, Whittaker VJ, Kunadian B, et al. Prospective randomized controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndrome. Heart. 2006;92:1278-1284. (Pubitemid 44298880)
26. Lee CH, Low A, Tai BC, et al. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study. Eur Heart J. 2007;28:19-25. (Pubitemid 46137813)